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Abstract: In a litter of Turkish Van cats, three out of six kittens developed severe signs of skin disease,
diarrhea, and systemic signs of stunted growth at 6 weeks of age. Massive secondary infections of
the skin lesions evolved. Histopathological examinations showed a mild to moderate hyperplastic
epidermis, covered by a thick layer of laminar to compact, mostly parakeratotic keratin. The dermis
was infiltrated with moderate amounts of lymphocytes and plasma cells. Due to the severity of the
clinical signs, one affected kitten died and the other two had to be euthanized. We sequenced the
genome of one affected kitten and compared the data to 54 control genomes. A search for private
variants in the two candidate genes for the observed phenotype, MKLN1 and SLC39A4, revealed
a single protein-changing variant, SLC39A4:c.1057G>C or p.Gly353Arg. The solute carrier family
39 member 4 gene (SLC39A4) encodes an intestinal zinc transporter required for the uptake of
dietary zinc. The variant is predicted to change a highly conserved glycine residue within the first
transmembrane domain, which most likely leads to a loss of function. The genotypes of the index
family showed the expected co-segregation with the phenotype and the mutant allele was absent
from 173 unrelated control cats. Together with the knowledge on the effects of SLC39A4 variants in
other species, these data suggest SLC39A4:c.1057G>C as candidate causative genetic variant for the
phenotype in the investigated kittens. In line with the human phenotype, we propose to designate
this disease acrodermatitis enteropathica (AE).
Keywords: Felis catus; whole genome sequencing; dermatology; genodermatosis; zinc
1. Introduction
Lethal acrodermatitis (LAD) is a monogenic autosomal recessive disease in Bull
Terriers and Miniature Bull Terriers (OMIA 002146-9615). It is characterized by skin lesions
on the feet and face, diarrhea, bronchopneumonia, and a failure to thrive [1–3]. Some
studies also observed a decreased plasma zinc level in LAD-affected dogs [2,4]. Oral or
parenteral supplementation of zinc, however, did not improve the clinical signs of these
dogs [1]. LAD in dogs is caused by a splice defect in the MKLN1 gene [5]. This gene
encodes the muskelin 1 protein, which is, intracellularly, widely expressed and is discussed
to be involved in several functions, including cell adhesion, morphology, spreading, and
intracellular transport processes [6–16]. To date, the exact pathogenesis of LAD has not
been elucidated [5].
Acrodermatitis enteropathica (AE) is a related phenotype, which is also inherited
as an autosomal recessive trait. It has been described in humans (OMIM # 201100) and
cattle (OMIA 000593-9913) [17,18]. The bovine disease was termed lethal trait A46, bovine
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hereditary zinc deficiency or Adema disease. Clinical findings were rapidly associated
with low plasma zinc levels [18–22].
Zinc ions (Zn2+) are essential for many biological processes. More than 300 enzymes
need zinc as an essential co-factor, and approximately 2800 human proteins are potentially
zinc-binding. In these metalloproteins, the binding of zinc is needed either because the
metal ion is involved in the catalytic mechanism, or because it stabilizes the protein tertiary
or quaternary structure [23,24]. In zinc-deficient individuals, the clinical manifestations are
correspondingly diverse.
AE in humans and cattle is caused by variants in the SCL39A4 gene, encoding the
solute carrier family 39 member 4, an intestinal zinc transporter that has also been termed
ZIP4 [25–28]. The loss of function of this transporter leads to a severe systemic zinc defi-
ciency. Untreated, the disease ends fatally. However, as there is another, non-saturable trans-
port pathway besides the high-affinity SLC39A4 transporter, the zinc deficit in AE patients
can be successfully treated with sufficient supplementation of oral zinc [18,19,21,28–34].
In the present study, we investigated a litter of Turkish Van cats with skin lesions
and additional clinical signs of zinc deficiency. The goal of the study was to characterize
the clinical and histopathological phenotype and to identify the underlying causative
genetic variant.
2. Materials and Methods
2.1. Animal Selection
This study included a Turkish Van cat family with 12 animals and 173 genetically
diverse control cats from other breeds. Genomic DNA was isolated from ETDA blood
samples with the Maxwell RSC Whole Blood Kit using a Maxwell RSC instrument (Promega,
Dübendorf, Switzerland).
2.2. Histopathological Examinations
Skin biopsies (6 mm punch and wedge incision) were taken under general anesthesia
from Case 1 and 2 at the time of presentation at 10 weeks of age, when Case 1 was
euthanized. Further biopsies were taken from Case 3 at the time of euthanasia, two weeks
after the initial presentation, at 12 weeks of age. Areas biopsied included the paw pads,
claw folds, axilla, inguinal region, and concave pinnae. From the euthanized kittens,
tissue samples were also taken from muco-cutaneous junctions, the thoracic esophagus,
stomach, and small intestine. The samples were fixed in 10% neutral buffered formalin and
routinely processed including staining with hematoxylin and eosin (HE) and periodic acid
Schiff (PAS).
2.3. Whole Genome Sequencing
An Illumina TruSeq PCR-free DNA library with ~400 bp insert size of an AE affected
Turkish Van cat was prepared. We collected 188 million 2 × 150 bp paired-end reads or
20.7× coverage on a NovaSeq 6000 instrument. The reads were mapped to the FelCat9.0
cat reference genome assembly and aligned as described [35]. The sequence data were
submitted to the European Nucleotide Archive with the study accession PRJEB7401 and
sample accession SAMEA8609184.
2.4. Variant Calling
Variant calling was performed as described [35]. The SnpEff software was used to
predict the functional effects of the called variants [36] together with NCBI annotation
release 104 for the FelCat9.0 genome reference assembly. For variant filtering, we used
54 control genomes (Supplementary Table S1). The control genomes were derived from
29 purebred cats of 8 different breeds and 25 random-bred domestic cats.
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2.5. Gene Analysis
Numbering within the feline SLC39A4 gene corresponds to the NCBI RefSeq accession
numbers XM_004000173.3 (mRNA) and XP_004000222.2 (protein). We performed a multi-
ple species comparison of orthologous SLC39A4 amino acid sequences with the accessions
NP_570901.2 (Homo sapiens), XP_001157597.3 (Pan troglodytes), XP_001098635.2 (Macaca
mulatta), XP_005628372.1 (Canis lupus familiaris), NP_001039532.1 (Bos taurus), NP_082340.1
(Mus musculus), and NP_001071137.1 (Rattus norvegicus). Protein alignments were either
directly taken from the precomputed NCBI HomoloGene database [37] or performed with
blastp on the NCBI BLAST server [38].
2.6. Sanger Sequencing
Sanger sequencing of PCR amplicons was used to confirm the candidate variant
SCL39A4:c.1057G>C and to genotype cats. With the primers 5′-GGA TGG GGC TTT AAG
GGT TA-3′ (Primer F) and 5′-GCT GAC CTT GGG TGT CAA GT-3′ (Primer R) a 334 bp PCR
product was amplified from genomic DNA using AmpliTaqGold360Mastermix (Thermo
Fisher Scientific, Waltham, MA, USA). After treatment with shrimp alkaline phosphatase
and exonuclease I, PCR amplicons were sequenced on an ABI 3730 DNA Analyzer (Thermo
Fisher Scientific). The Sequencher 5.1 software was used to analyze the Sanger sequences
(GeneCodes, Ann Arbor, MI, USA).
3. Results
3.1. Family Anamnesis, Clinical Examinations and Histopathology
A 10 week-old Turkish Van litter was referred due to a 4 week history of rapidly
progressing, severe dermatological and systemic disease in three out of six kittens. The
phenotype distribution was suggestive of a monogenic autosomal recessive mode of
inheritance (Figure 1).
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Figure 1. Pedigree of the investigated Turkish Van family. Squares represe t l
females. The three affected kittens are numbered and indicated by filled symbols. Genotypes at the
SCL39A4:c.1057G>C variant are indicated.
All kittens had a normal dev lopment and growth until 6 weeks of age. The mother
was healthy. Star ing from 6–8 weeks of age, the three affect d kittens displayed sim lar
systemic and dermatological signs of varying sev rity. The affect d cats showed growth
retardation a d developed diarrhea. Dermatological signs ncluded widespread and severe
scaling, alopecia, and moist ermatitis as well s numerous erosions and focal ulcerations.
Lesions had a predominantly ventral a d distal istribution, most sever ly in friction
areas but also around mucocutaneous junctions, concave pinnae and paw pads (Figure 2).
Furthermore, there was a widespread and severe secondary pyoderma. Interdigital crusts
and erosions were present in clawfolds, but the cla s ere nor al. Several paw pads
had splitting lesions in a horizontal direction across the complete pad and erosions or
ulcerations in the junction between paw pad and skin (Figure 2d). There were no visible
oral lesions and teeth were normal. Systemic signs included anorexia, fever, dehydration,
decreased body weight (on average 40% less than unaffected siblings). Thoracic auscul-
tation, abdominal and lymph node palpation were all unremarkable. Prior to referral,
the affected kittens had tested negative for Demodex gatoi and for dermatophytosis via a
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PCR test. Clinical signs had not improved upon treatment with systemic amoxicillin and
prednisolone for 5 days. Complete blood counts were unremarkable.
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Figure 2. Clinical phenotype of cats affected with AE. (a) Skin disease with erythema and beginning
alopecia on the ventrum. (b) More severe presentation with erythema, crusting, scaling, and alopecia
on the ventral and distal aspects. (c) Characteristic skin lesions in th face and t e ar pi nae.
(d) Interdigital erosions.
The histological findings were similar in all samples from the three kittens. The epi-
dermis was mildly to moderately hyperplas ic, and the granular cell layer was thin to
absent. Few apoptotic cells were present in the superficial epidermis in some samples.
The epidermis was diffusely covered by variable amounts of laminar to compact, parak-
eratotic keratin, characterized by retained nuclei in the stratum corneum. In between the
corneocytes, numerous cocci and/or yeasts were present. Multifocally, the biopsies were
covered by large serocellular crusts, composed of corneocytes, proteinaceous material,
degenerate inflamm tory cells, and abund nt cocci. In the epid rmis, underneath some of
the crusts, spongiosis and leukocyte exocytosis was present. In the superficial dermis, a
mild perivascular infiltrate composed of mast cells, few lymphocytes and rare plasma cells
was noted. In the biopsies of one kitten, there were also some eosinophils. Multifocally, the
epidermis was ulcerated and there were abundant inflammatory cells underneath the ulcer
(Figure 3). Findings in non-haired skin from the paw pads were similar (Figure 3b).
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abundant infla matory cells in the superficial dermis underneath the ulcer (filled arrows). (d) Skin of a healthy cat as
control showing the epidermis of normal thickness covered by basketweave orthokeratotic keratin together with the dermis
and the adnexa (filled arrows).
Two affected kittens were euthanized due to rapidly progressing and s vere gen-
eralize dise se at 10 (Case 1) and 12 (Cas 3) we ks of age. The third affected kitten,
Case 2, appeared relatively bright, playful and gain d weight, until 12 weeks of age, when
it suddenly and rapidly deteriorated and died before it could be euthanized. The three
unaffected siblings have continued to grow and develop into healthy adult individuals.
3.2. Genetic Analysis
In order to characterize the underlying causative genetic variant, we sequenced the
genome of Case 2 at 20.7× coverage and searched for homozygous variants in MKLN1
and SLC39A4, the two candidate genes for the observed phenotype. We filtered for private
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variants, which were exclusively present in the affected cat and absent from the genomes
of 54 other cats (Table 1 and Supplementary Tables S1 and S2).
Table 1. Results of variant filtering in the affected Turkish Van cat against 54 control genomes. Only
homozygous variants are reported.
Filtering Step Variants
all variants in the affected cat 5,518,410
private variants 56,054
protein-changing private variants 161
protein-changing private variants in MKLN1 or SLC39A4 1
This analysis identified a single homozygous private protein-changing candidate
variant in SLC39A4. The variant can be designated as ChrF2:85,320,523C>G (FelCat9.0).
It was a missense variant, XM_004000173.3:c.1057G>C, predicted to change a highly
conserved glycine residue in the first transmembrane domain of the zinc transporter,
XP_004000222.2:p.(Gly353Arg).
We confirmed the presence of the SLC39A4 missense variant by Sanger sequencing
(Figure 4). Genotypes at the variant perfectly co-segregated with the phenotype in the
available family members. All three affected cats were homozygous. The parents and two
close relatives carried the mutant allele in a heterozygous state. All other non-affected cats
were homozygous for the wildtype allele (Figure 1).
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Figure 4. Details of the SLC39A4:c.1057G>C, p.Gly353Arg variant. (a) Representative electrophero-
grams of three cats with different genotypes are shown. The variable position is indicated by an arrow
and the amino acid translations are shown. (b) Model of SLC39A4 membrane topology, modified
from [39]. The positions of six functionally characterized missense variants identified in human AE
patients are indicated. The position of the feline p.Gly353Arg variant identified in the investigated
cat is indicated in red. (c) Multiple-species alignment of the SLC39A4 amino acid sequences in the
region harboring the p.Gly353Arg variant. The variant affects a highly conserved glycine residue.
The sequence of the first transmembrane domain is underlined.
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We determined the genotypes at SLC39A4:c.1057G>C for the index family as well as
173 other cats. The mutant allele was exclusively detected in the Turkish Van family and not
in cats from other breeds. All non-affected cats were either heterozygous or homozygous
for the wildtype allele (Table 2).
Table 2. Genotype–phenotype association of the SCL39A4:c.1057G>C variant with AE.
Cats G/G G/C C/C
Cases (n = 3) - - 3
Controls, Turkish Van cats from index family (n = 9) 5 4 -
Controls, other breeds (n = 173) 173 - -
4. Discussion
The characteristic clinical signs and the early age of onset in the three affected cats
described in this study strongly suggested the presence of an inherited disease. The clinical
phenotype mostly resembled that of lethal acrodermatosis (LAD), previously described
in Bull Terriers and Miniature Bull Terriers, and acrodermatitis enteropathica (AE), which
is known in humans and was also described in cattle under the name lethal trait A46,
bovine hereditary zinc deficiency, or Adema disease [1–3,17,18]. The histopathological
findings are unique and have not been reported in cats before. They strikingly resembled
the findings seen in lethal acrodermatitis in Bull terriers and miniature Bull terriers [1–5] or
other disorders associated with impaired zinc absorption, such as canine zinc responsive
dermatosis [40,41] or bovine hereditary zinc deficiency [17,18]. Another disorder with
diffuse parakeratosis described in dogs and very rarely in cats is superficial necrolytic
dermatosis; however, this disorder is associated with either hepatic disease or hepatic or
pancreatic neoplasia and seen in much older individuals. Thallium toxicosis also presents
with severe parakeratotic hyperkeratosis but is very unlikely in such young kittens and is
nowadays rare, since thallium was banned as rodenticide [40,41]. A last differential would
have been a generalized form of non-epidermolytic ichthyosis with secondary infection.
However, in generalized ichthyosis, the stratum corneum is usually orthokeratotic [40,41].
The genome of one affected cat was sequenced and filtered for private variants in
the two candidate genes for both differential diagnoses. The analysis revealed a private
missense variant in the SLC39A4 gene encoding the solute carrier family 39 member
4, a zinc transporter with eight transmembrane domains, which is responsible for the
saturable zinc uptake in the small intestine [29,39]. Loss of function of SLC39A4 leads
to a severe zinc deficiency, which ends fatally if untreated. The fact that there is another,
unsaturable intestinal zinc transport pathway enables the treatment of the deficiency with
oral supplementation of large doses of zinc [18,19,21,28–34].
Missense variants in transmembrane domains were previously described to impair
the function of SLC39A4 [39]. So far, one variant in the first transmembrane domain has
been reported in a human patient [26]. The identified missense variant in the affected cats
changes a highly conserved glycine residue in the first transmembrane domain. We assume
that the change in the uncharged glycine to the positively charged arginine is intolerable
for the integration of the protein in the membrane, thus causing a complete loss of function
of the transporter. This hypothesis is further supported by the fact that four of the known
pathogenic human variants involve an exchange of a glycine within a transmembrane
domain to a charged amino acid.
We have to caution that we did not experimentally confirm the loss of function
of SLC39A4 on the protein level. While the comparative data from human and cattle
clearly suggest that SLC39A4:c.1057G>C is a very likely candidate causative variant for
the observed skin lesions in the affected cats, further experiments are required to obtain
definitive proof for this hypothesis.
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5. Conclusions
In this study, we provide the first report of acrodermatitis enteropathica in cats. The
identification of a candidate causative variant, SLC39A4:c.1057G>C, enables genetic testing
to prevent future breeding of affected cats. For affected kittens, the genetic test also offers
the chance to initiate adequate therapy, since AE is treatable with oral zinc supplementation.
Supplementary Materials: The following are available online at https://www.mdpi.com/article/10
.3390/genes12091309/s1, Table S1: Accession numbers of 55 cat genome sequences. Table S2: Private
variants in the sequenced Turkish Van cat with acrodermatitis enteropathica (AE).
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